vesnarinone has been researched along with Leukemia, Myeloid in 1 studies
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, S | 1 |
| Tomoyasu, S | 1 |
| Okabe-Kado, J | 1 |
| Hozumi, M | 1 |
| Tsuruoka, N | 1 |
| Nakai, S | 1 |
| Adachi, M | 1 |
| Honma, Y | 1 |
1 other study available for vesnarinone and Leukemia, Myeloid
| Article | Year |
|---|---|
Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium; Cardiotonic Agents; Cell Different | 1996 |